Sinus-Wash Pilot Study

Phase 1

• Conditions: Covid-19; MedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 100000004862; Therapeutic area: Diseases [C] - Virus Diseases [C02]

• Registration Number: EUCTR2020-001721-31-GB
• Lead Sponsor: Hampshire Hospitals NHS TRust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-27
• Last Update Posted: 11 May 2020

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Staff who have tested positive for COVID -19 AND in isolation at home.
Patients who have been tested positive for Covid-19 on general wards or about to be discharged who are well enough to self administer nasal washes.
Household member of affected staff member and household members of affected patients on general ward once discharged to home self-isolation
18 years and over

Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

Known hypersensitivity to Iodine
Those at risk of aspiration due to unsafe swallow
Those unable to perform treatment themselves
Under 18 years of age

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified